Thermo Fisher Scientific TMO Other — Consolidated revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Thermo Fisher Scientific’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's other — consolidated revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Thermo Fisher Scientific's other — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported other — consolidated revenues of $5.58B in Q4 2025.
- How has Thermo Fisher Scientific's other — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's other — consolidated revenues increased by 5.6% year-over-year, from $5.28B to $5.58B.
- What is the long-term trend for Thermo Fisher Scientific's other — consolidated revenues?
- Over 2 years (2023 to 2025), Thermo Fisher Scientific's other — consolidated revenues has grown at a 3.5% compound annual growth rate (CAGR), from $20.84B to $22.32B.
- What does other — consolidated revenues mean?
- This metric represents the total revenue generated by business activities or geographic regions categorized as 'Other' within the company's segment reporting structure. It captures income streams that do not fall under the primary operating segments, often including corporate-level adjustments, non-core business units, or emerging geographic markets. Monitoring this figure helps investors understand the contribution of peripheral operations to the overall top-line performance.